CompletedNot Applicable

Effects of Microgalvanic Current on Body Satisfaction and Quality of Life in Women With Striae Alba

Brazil61 participantsStarted 2024-04-08

Plain-language summary

The purpose of this randomized clinical trial is to determine whether microgalvanic current can improve quality of life and body satisfaction in women aged 20 to 35 years with striae albae (white stretch marks). The primary research question is: Does microgalvanic current improve body satisfaction or quality of life? The secondary research question is: Does microgalvanic current lead to clinical improvement of striae albae? Participants will be randomly assigned to one of two groups: Control group: device turned off, receiving microneedling only; and Intervention group: active device, receiving microneedling combined with microgalvanic current. All participants will undergo 10 weekly treatment sessions, each lasting approximately 50 minutes. Baseline and post-intervention assessments will be conducted to evaluate primary and secondary outcomes. Standardized photographs of the affected areas will be obtained to assess clinical improvement.

Who can participate

Age range

20 Years – 35 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Biologically female individuals * Age between 20 and 35 years * Presence of white stretch marks (striae albae) * Availability to participate for the entire duration of the study * Properly and completely signed Informed Consent Form, Image Use Agreement and all study questionnaires Exclusion Criteria: * Cardiac arrhythmia or pacemaker * Hemophilia * Uncontrolled arterial hypertension * Diabetes mellitus * Predisposition to keloid formation * Hypersensitivity to electrical current stimulation * Pregnancy * Any abnormalities or diseases (e.g., Cushing's syndrome) that impair skin healing * Open wounds * Current or recent use of corticosteroids, steroids or anti-inflammatory medications

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Quality of Life Assessed by Dermatology Life Quality Index (DLQI)

Timeframe: Baseline (before the first treatment session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).

Impact of Stretch Marks on Quality of Life Assessed by Structured Interview

Timeframe: Baseline (before the first treatment session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).

Body Satisfaction

Timeframe: Baseline, pre- (before the first session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).

Trial details

NCT IDNCT07455669

SponsorFederal University of the Valleys of Jequitinhonha and Mucuri

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-01

View on ClinicalTrials.gov More White Stretch Marks (Striae Albae) trials

Plain-language summary

Who can participate

Age range

20 Years – 35 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Quality of Life Assessed by Dermatology Life Quality Index (DLQI)

Timeframe: Baseline (before the first treatment session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).

Impact of Stretch Marks on Quality of Life Assessed by Structured Interview

Timeframe: Baseline (before the first treatment session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).

Body Satisfaction

Timeframe: Baseline, pre- (before the first session) and post-intervention (after 10 treatment sessions, approximately 10 weeks).